首页> 外文期刊>Journal of Evidence-Based Integrative Medicine >Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial:
【24h】

Silymarin, Olibanum, and Nettle, A Mixed Herbal Formulation in the Treatment of Type II Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial:

机译:水飞蓟素,Olibanum和荨麻,一种治疗II型糖尿病的混合草药制剂:一项随机,双盲,安慰剂对照的临床试验:

获取原文
获取外文期刊封面目录资料

摘要

Silybum marianum (L) Gaertn (milk thistle) seeds, Urtica dioica L (nettle) leaves, and Boswellia serrata (olibanum gum) resin are used traditionally by Iranian diabetic patients. The aim of this study was to evaluate the antihyperglycemic effects of these herbs in an herbal formulation in patients with type II diabetes mellitus. Sixty patients diagnosed as type II diabetes mellitus with fasting blood glucose level from 150 to 180 mg/dL, glycosylated hemoglobin level from 7.5% to 8.5%, and on oral antihyperglycemic drugs, were allocated to receive the mix herbal formulation or placebo for 90 days in a double-blind randomized placebo-controlled clinical trial. The mean serum fasting blood glucose, glycosylated hemoglobin, and triglyceride in the herbal drug group were significantly less than placebo group’s values after 3 months of the intervention. The study showed a potential antihyperglycemic and triglyceride lowering effect of the herbal formulation, while it did not have any significant cholesterol or blood pressure lowering effect.
机译:伊朗糖尿病患者传统上使用水飞蓟(L)Gaertn(奶蓟)种子,荨麻叶(荨麻)叶和乳香乳香(olibanum gum)树脂。这项研究的目的是评估这些草药在II型糖尿病患者中的降血糖作用。 60名被诊断为II型糖尿病的患者被分配接受混合草药制剂或安慰剂治疗90天,这些患者的空腹血糖水平为150至180 mg / dL,糖基化血红蛋白水平为7.5%至8.5%,并口服口服降糖药在一项双盲随机安慰剂对照临床试验中。干预3个月后,草药组的平均血清禁食血糖,糖基化血红蛋白和甘油三酯明显低于安慰剂组。研究表明,该草药配方具有潜在的降血糖和降甘油三酸酯的作用,而对胆固醇或血压没有明显的降低作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号